Cargando…
ALYREF mediates RNA m(5)C modification to promote hepatocellular carcinoma progression
Autores principales: | Xue, Chen, Gu, Xinyu, Zheng, Qiuxian, Shi, Qingmiao, Yuan, Xin, Su, Yuanshuai, Jia, Junjun, Jiang, Jianwen, Lu, Juan, Li, Lanjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024699/ https://www.ncbi.nlm.nih.gov/pubmed/36934090 http://dx.doi.org/10.1038/s41392-023-01395-7 |
Ejemplares similares
-
Effects of 3‐HAA on HCC by Regulating the Heterogeneous Macrophages—A scRNA‐Seq Analysis
por: Xue, Chen, et al.
Publicado: (2023) -
Intratumoral bacteria interact with metabolites and genetic alterations in hepatocellular carcinoma
por: Xue, Chen, et al.
Publicado: (2022) -
Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes
por: Xue, Chen, et al.
Publicado: (2022) -
Multi-Omic Analyses of the m(5)C Regulator ALYREF Reveal Its Essential Roles in Hepatocellular Carcinoma
por: Xue, Chen, et al.
Publicado: (2021) -
LncRNA PCGEM1 in Human Cancers: Functions, Mechanisms and Promising Clinical Utility
por: Su, Yuanshuai, et al.
Publicado: (2022)